These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 1219805)

  • 21. Trapidil and other 5-triazolo-(1, 5-alpha)-pyrimidine derivatives as calcium channel blockers in 108CC5 cells.
    Hering S; Bodewei R; Schubert B; Krause EG; Wollenberger A
    Biomed Biochim Acta; 1985; 44(5):K37-41. PubMed ID: 2415119
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The modification of the biosynthesis and effect of thromboxane A2 and prostacyclin by trapidil (Rocornal)].
    Block HU; Heinroth I; Giessler C; Pönicke K; Mentz P; Zehl U; Rettkowski W; Dunemann A; Förster W
    Biomed Biochim Acta; 1983; 42(2-3):283-99. PubMed ID: 6411078
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bioavailability of trapidil tablets.
    Weiss M; Sziegoleit W; Pönicke K; Schobess M; Fahr A; Mest HJ
    Arzneimittelforschung; 1989 Sep; 39(9):1137-8. PubMed ID: 2590264
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Analysis of relaxant effects of trapidil in isolated dog coronary artery.
    Sakanashi M; Yoshikawa Y; Kondoh G; Fukai R; Hirata A; Higuchi M
    Arzneimittelforschung; 1980; 30(11):1871-4. PubMed ID: 7192995
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Is there a renaissance for trapidil?].
    Mest HJ; Thomas E
    Z Gesamte Inn Med; 1986 Apr; 41(8):217-20. PubMed ID: 3727643
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The effectiveness of trapidil and some derivatives on heart function under in vitro and in vivo conditions].
    Mentz P; Pawelski KE; Orlova ZR; Giessler C; Mest HJ
    Pharmazie; 1987 Jun; 42(6):403-6. PubMed ID: 3313438
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Oral trapidil treatment of Fontaine stage II arteriosclerotic circulatory disorders of the legs--a double-blind study].
    Voigt H; Reuter W; Hofmann B; Dobberkau A
    Z Gesamte Inn Med; 1990 May; 45(10):283-7. PubMed ID: 2392858
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bronchodilatory effect of trapidil in man.
    Ikeda H; Takahashi K; Sato S; Sasaki H; Ito E; Yasui S
    Arzneimittelforschung; 1984; 34(3):309-13. PubMed ID: 6539612
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of trapidil on regional myocardial function during acute coronary occlusion in the dog.
    Takahashi M; Sasayama S; Nakamura M; Hirose K; Kawai C
    Arzneimittelforschung; 1982; 32(3):214-8. PubMed ID: 7200778
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The effectiveness of trapidil and trapidil derivatives on drug-induced heart arrhythmias in the rat and guinea pig].
    Riedel A; Schneider S; Mest HJ
    Arzneimittelforschung; 1987 Aug; 37(8):923-6. PubMed ID: 3675688
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Simultaneous determination of trapidil and its metabolites in serum by high-performance liquid chromatography].
    Nakagawa H; Maeyama S; Higashitani T; Nakahata K; Hoshino F; Fukui Y
    Yakugaku Zasshi; 1984 Jun; 104(6):635-9. PubMed ID: 6502456
    [No Abstract]   [Full Text] [Related]  

  • 32. Suppression of fibroblast proliferation in vitro and of myointimal hyperplasia in vivo by the triazolopyrimidine, Trapidil.
    Tiell ML; Sussman II; Gordon PB; Saunders RN
    Artery; 1983; 12(1):33-50. PubMed ID: 6678578
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacokinetics of trapidil (Rocornal) in patients with chronic liver disease.
    Berndt A; Pönicke K; Weiss M
    Int J Clin Pharmacol Ther Toxicol; 1992 Nov; 30(11):492-3. PubMed ID: 1490801
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Inhibition of thrombocyte spreading and the formation of thrombus-like aggregates bound with substrate by the anti-anginal agent trapidil].
    Mazurov AV; Leĭtin VL; Repin VS
    Vopr Med Khim; 1984; 30(4):110-6. PubMed ID: 6438908
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Modification of pulmonary hypertension in patients with chronic obstructive lung diseases by trapidil (Rocornal) in an acute trial].
    Schauer J; Orschekowski H; Winkler J; Steiniger L
    Z Erkr Atmungsorgane; 1991; 177(3):204-16. PubMed ID: 1808871
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Action of trapidil on the heart contractility: relationship to the cyclic nucleotide metabolism.
    Bartel S; Reese D; Krause EG
    Biomed Biochim Acta; 1987; 46(8-9):S472-6. PubMed ID: 2829868
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Protective effect of thromboxane A2 synthetase inhibitor (trapidil) on acutely-induced cerebral ischemia].
    Katayama Y; Shimizu J; Memezawa H; Minamisawa H; Suzuki S; Sugimoto S; Terashi A
    No To Shinkei; 1986 Oct; 38(10):925-31. PubMed ID: 3790357
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Pharmacokinetics of trapymin (Rocornal)].
    Preifer S; Borchert HH; Bornschein I; Meyer-Kollar R
    Pharmazie; 1972 Dec; 27(12):749-52. PubMed ID: 4664645
    [No Abstract]   [Full Text] [Related]  

  • 39. [Excretion of trapymin (Rocornal)].
    Pfeifer S; Wierer A; Bornschein I; Rabitzsch G
    Pharmazie; 1972 Dec; 27(12):752-5. PubMed ID: 4664646
    [No Abstract]   [Full Text] [Related]  

  • 40. Influence of aspirin, molsidomine, trapidil, and some trapidil derivatives on arachidonic acid induced reversible thrombocyte aggregation in the rabbit.
    Zehl U; Mest HJ; Förster W
    Biomed Biochim Acta; 1984; 43(8-9):S381-4. PubMed ID: 6440554
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.